myristic acid has been researched along with Astrocytoma, Grade IV in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Gao, H; Gu, B; Li, J; Lu, W; Meng, Q; Yan, Z; Yang, X | 1 |
| Baserga, R; Hongo, A; O'Connor, R; Resnicoff, M; Romano, G; Yumet, G | 1 |
2 other study(ies) available for myristic acid and Astrocytoma, Grade IV
| Article | Year |
|---|---|
The use of myristic acid as a ligand of polyethylenimine/DNA nanoparticles for targeted gene therapy of glioblastoma.
Topics: Animals; Brain; Cell Line, Tumor; DNA; Genetic Therapy; Glioblastoma; Humans; Mice; Myristic Acid; Nanoparticles; Polyethyleneimine; TNF-Related Apoptosis-Inducing Ligand; Transfection | 2011 |
Inhibition of tumorigenesis and induction of apoptosis in human tumor cells by the stable expression of a myristylated COOH terminus of the insulin-like growth factor I receptor.
Topics: Animals; Apoptosis; Cell Transformation, Neoplastic; Female; Glioblastoma; Humans; Mice; Mice, Nude; Myristic Acid; Neoplasm Transplantation; Neoplastic Stem Cells; Ovarian Neoplasms; Peptide Fragments; Receptor, IGF Type 1; Transfection; Tumor Cells, Cultured | 1998 |